Response to "SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients".
作者信息
Malinis Maricar, Cohen Elizabeth, Azar Marwan M
机构信息
Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.
Yale New Haven Transplant Center, New Haven, Connecticut, USA.
出版信息
Am J Transplant. 2021 Dec;21(12):4106-4107. doi: 10.1111/ajt.16770. Epub 2021 Aug 12.
Abstract
摘要
相似文献
1
Response to "SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients".
Am J Transplant. 2021 Dec;21(12):4106-4107. doi: 10.1111/ajt.16770. Epub 2021 Aug 12.
2
SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients.
Am J Transplant. 2021 Dec;21(12):4105. doi: 10.1111/ajt.16744. Epub 2021 Jul 16.
3
Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients.
Am J Transplant. 2021 Aug;21(8):2913-2915. doi: 10.1111/ajt.16607. Epub 2021 May 7.
4
Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients.
Am J Transplant. 2021 Aug;21(8):2916-2918. doi: 10.1111/ajt.16713. Epub 2021 Jul 10.
5
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients.
Am J Transplant. 2022 Jan;22(1):322-323. doi: 10.1111/ajt.16775. Epub 2021 Aug 31.
6
Reconciling short-term clinical and immunological outcomes of SARS-CoV-2 vaccination in solid organ transplant recipients.
Am J Transplant. 2022 Feb;22(2):673-675. doi: 10.1111/ajt.16855. Epub 2021 Oct 5.
7
Update on COVID-19 vaccination in pediatric solid organ transplant recipients.
Pediatr Transplant. 2022 Aug;26(5):e14235. doi: 10.1111/petr.14235. Epub 2022 Jan 20.
8
COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination.
Am J Transplant. 2021 Oct;21(10):3496-3499. doi: 10.1111/ajt.16618. Epub 2021 May 18.
9
Pediatric solid organ transplant recipients demonstrate robust cell-mediated and humoral responses to three doses of mRNA SARS-CoV-2 vaccine.
Am J Transplant. 2022 Dec;22(12):3047-3052. doi: 10.1111/ajt.17195. Epub 2022 Sep 21.
10
Clinical effectiveness of additional primary SARS-CoV-2 vaccine doses for solid organ transplant recipients.
Clin Transplant. 2022 Mar;36(3):e14601. doi: 10.1111/ctr.14601. Epub 2022 Jan 28.
引用本文的文献
1
Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study.
Transplantation. 2022 Aug 1;106(8):1622-1628. doi: 10.1097/TP.0000000000004178. Epub 2022 May 3.
本文引用的文献
1
SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients.
Am J Transplant. 2021 Dec;21(12):4105. doi: 10.1111/ajt.16744. Epub 2021 Jul 16.
2
Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients.
Am J Transplant. 2021 Aug;21(8):2916-2918. doi: 10.1111/ajt.16713. Epub 2021 Jul 10.
3
Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients.
Transplantation. 2021 Aug 1;105(8):e82-e83. doi: 10.1097/TP.0000000000003850.
4
Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients.
Transplantation. 2021 Oct 1;105(10):2170-2174. doi: 10.1097/TP.0000000000003780.
5
Lack of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Large Cohort of Previously Infected Persons.
Clin Infect Dis. 2021 Nov 2;73(9):e3066-e3073. doi: 10.1093/cid/ciaa1685.
6
Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients.
Emerg Infect Dis. 2020 Oct;26(10):2484-2487. doi: 10.3201/eid2610.202211. Epub 2020 Jun 24.
Zotero 插件